Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Management of Osteoporosis in Women Aged 85 Years and Older

Pharmacologic Treatment Recommendations

  • The American College of Physicians recommends that women in their late 80s or older with osteoporosis diagnosed by bone density scan should be offered pharmacologic treatment with bisphosphonates as first-line therapy, combined with adequate calcium and vitamin D supplementation, along with fall prevention strategies 1

Critical Evidence Gap and Clinical Approach

  • There is limited data on osteoporosis treatment in women older than 85 years of age, as acknowledged by major guidelines such as the American College of Physicians 2, 3

Essential Non-Pharmacologic Interventions

  • Ensure adequate calcium intake of 1000-1200 mg daily, as recommended by the National Osteoporosis Foundation 1
  • Provide vitamin D supplementation of 800-1000 IU daily, as recommended by the National Osteoporosis Foundation 1
  • Implement comprehensive fall prevention strategies, as falls are the proximate cause of most osteoporotic fractures in elderly women, according to the Centers for Disease Control and Prevention 1

Monitoring and Follow-Up

  • Schedule annual clinical assessments to evaluate treatment adherence, side effects, and occurrence of new fractures, as recommended by the American College of Physicians 1
  • Repeat DXA scanning in 1-2 years for patients on treatment to monitor effectiveness, as recommended by the International Society for Clinical Densitometry 4
  • A minimum of 2 years is needed to reliably measure changes in bone mineral density, according to the National Institutes of Health 2, 4, 5

Critical Considerations for Very Elderly Patients

  • Do not withhold treatment based solely on advanced age, as the evidence gap does not mean lack of benefit, according to the American Geriatrics Society 2, 3
  • Ensure patient education about treatment options and their benefits/risks to facilitate informed choice and improve adherence, as recommended by the National Committee for Quality Assurance 1

Lifestyle Modifications

  • Advise smoking cessation if applicable, as benefits occur at any age, according to the US Department of Health and Human Services 6

REFERENCES

1

Osteoporosis Screening and Management in Women Aged 65-85 Years [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Osteoporosis Screening and Diagnosis in Postmenopausal Women [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Smoking Cessation for Osteoporosis Risk Reduction [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025